Schellhorn out, Emerson in as Monteris CEO
Emerson spent 8 years as prez & CEO of Galil Medical, which was acquired in June this year by BTG (LON:BTG). Prior to his time with Galil, Emerson acted as prez and CEO of American Medical Systems Holdings, and has held positions at Boston Scientific (NYSE:BSX) and Baxter (NYSE:BAX).
“We are pleased and privileged to have an executive with Marty Emerson’s experience and track record take over the reins at Monteris Medical. He has both the leadership and market knowledge necessary to build Monteris into a world-class medical device company,” Monteris Medical board chair Greg Barrett said in a press release.
“I would like to thank the Monteris board of directors for the opportunity to lead a company with such exciting technology offering minimally invasive surgical alternatives to patients with brain tumors and epilepsy. I look forward to working with the talented Monteris management team to meet the high expectations of the company’s investors, physicians and their patients,” Emerson said in prepared remarks.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.